Assessing Response Using ^𝟗𝟗𝐦Tc-MIBI Early after Interstitial Chemotherapy with Carmustine-Loaded Polymers in Glioblastoma Multiforme: Preliminary Results

Table 1

Patients and data considered in the statistical analysis.

Age	Sex	Completeness; of resection	First diagnosis/; recurrent disease	Gliadel; (yes/no)	MIBI ratio; BS	MIBI ratio; early AS	MIBI ratio; 4-month AS
69	M	Yes	FD	Yes	24.3	3.5	7.9
64	M	Yes	RD	Yes	23.0	1.0	1.4
58	M	Yes	RD	Yes	19.6	10.0	//
45	M	No	RD	Yes	46.1	15.7	//
58	M	Yes	FD	Yes	14.9	2.4	1.4
59	M	No	FD	Yes	11.0	5.5	//
54	M	Yes	RD	Yes	21.0	3.1	3.4
68	M	Yes	RD	Yes	13.6	10.2	10.3
46	M	No	RD	Yes	14.2	11.6	//
54	M	Yes	RD	Yes	11.1	3.6	//
51	F	Yes	RD	Yes	39.7	9.2	//
58	M	No	FD	Yes	12.5	4.8	5.6
39	F	Yes	RD	Yes	2.4	1.9	//
62	F	No	FD	Yes	17.3	6.9	27.9
66	M	Yes	FD	Yes	17.3	8.4	10.9
51	M	Yes	FD	No	5.6	9.5	19.3
74	M	No	FD	No	14.0	29.4	29.8
75	F	No	FD	No	10.6	17.4	9.0
62	M	Yes	FD	No	40.8	20.1	//
57	M	No	FD	No	11.6	1.2	2.4
72	F	Yes	FD	No	24.0	3.1	6.0
57	M	Yes	FD	No	15.9	2.3	29.7
84	F	Yes	FD	No	3.6	1.7	4.1

FD: first diagnosis; RD: recurrent disease; BS: before surgery; AS: after surgery.